|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
According to the reporter, on (b)(6) 2025, the catheter was used for a second dialysis session.Despite adjustments, blood flow remained inadequate, and the machine repeatedly alarmed, making it impossible to perform effective dialysis.As a result, the patient only received a brief dialysis session, insufficient for adequate treatment.The dialysis was prematurely terminated, shortening the session duration and autogenous arteriovenous fistula was planned as an alternative vascular access.There was no reported patient outcome.
|